Genetic Testing
Comprehensive genetic analysis for disease risk, pharmacogenomics, and personalized health optimization.
Evidence Summary
BRCA, APOE, and other variants well-validated for risk. Pharmacogenomics increasingly standard. Polygenic risk scores evolving rapidly.
Evidence Scale
Mechanism of Action
DNA analysis identifies variants affecting disease risk, drug metabolism, nutrient needs, and health optimization opportunities.
Who Is This For?
Personalized prevention, pharmacogenomics, family planning, curiosity. Consider psychological readiness.
Protocol & Dosing
Dose
Single test providing lifetime information. Various depths of analysis available.
Frequency
Once (lifetime)
Duration
Results permanent
Protocol Summary
Saliva or blood sample. Various test depths from consumer to medical-grade. Genetic counseling recommended for significant findings.
Interactions & Precautions
Contraindications
- None for testing
- Psychological readiness considerations
Potential Risks
- •Psychological impact
- •Uncertainty in interpretation
- •Privacy concerns
Potential Side Effects
Practitioner Notes
Clinical annotations from Dr. Goel
Pharmacogenomics immediately actionable. APOE useful for Alzheimer prevention strategies. Consider genetic counseling for significant findings.
Dr. Sanjeev Goel
Chief Medical Officer, Peak Human
Cost & Access
Cost Range
$$
Accessibility
Availability varies by location
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation